Rock Springs Capital Management as of March 31, 2014
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 75 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Johnson & Johnson (JNJ) | 5.7 | $25M | 250k | 98.23 | |
Gilead Sciences (GILD) | 5.4 | $24M | 331k | 70.86 | |
Abbvie (ABBV) | 4.3 | $19M | 360k | 51.40 | |
Biogen Idec (BIIB) | 3.9 | $17M | 55k | 305.86 | |
McKesson Corporation (MCK) | 3.7 | $16M | 92k | 176.57 | |
UnitedHealth (UNH) | 3.4 | $15M | 181k | 81.99 | |
Thoratec Corporation | 3.3 | $14M | 401k | 35.81 | |
Amgen (AMGN) | 3.3 | $14M | 115k | 123.34 | |
InterMune | 3.2 | $14M | 410k | 33.47 | |
Thermo Fisher Scientific (TMO) | 3.0 | $13M | 107k | 120.24 | |
Health Care SPDR (XLV) | 2.7 | $12M | 200k | 58.49 | |
Actavis | 2.7 | $12M | 56k | 205.85 | |
Celgene Corporation | 2.5 | $11M | 77k | 139.60 | |
Flamel Technologies | 2.3 | $10M | 750k | 13.40 | |
Bristol Myers Squibb (BMY) | 2.2 | $9.6M | 186k | 51.95 | |
Agilent Technologies Inc C ommon (A) | 2.0 | $8.7M | 155k | 55.92 | |
CVS Caremark Corporation (CVS) | 1.9 | $8.5M | 113k | 74.86 | |
Cooper Companies | 1.9 | $8.3M | 61k | 137.36 | |
Intuitive Surgical (ISRG) | 1.9 | $8.1M | 19k | 438.00 | |
Humana (HUM) | 1.7 | $7.4M | 66k | 112.72 | |
Alexion Pharmaceuticals | 1.7 | $7.4M | 49k | 152.12 | |
Valeant Pharmaceuticals Int | 1.6 | $7.0M | 53k | 131.83 | |
Illumina (ILMN) | 1.5 | $6.3M | 43k | 148.66 | |
Team Health Holdings | 1.2 | $5.4M | 121k | 44.75 | |
Orexigen Therapeutics | 1.2 | $5.4M | 830k | 6.50 | |
Cardinal Health (CAH) | 1.2 | $5.3M | 76k | 69.97 | |
Forest Laboratories | 1.1 | $5.0M | 54k | 92.28 | |
Neurocrine Biosciences (NBIX) | 1.1 | $4.8M | 300k | 16.10 | |
HeartWare International | 1.1 | $4.7M | 50k | 93.78 | |
Walgreen Company | 1.1 | $4.7M | 71k | 66.03 | |
Envision Healthcare Hlds | 1.1 | $4.7M | 138k | 33.83 | |
Perrigo Company (PRGO) | 1.0 | $4.4M | 29k | 154.67 | |
Intercept Pharmaceuticals In | 1.0 | $4.3M | 13k | 329.77 | |
Pacira Pharmaceuticals (PCRX) | 1.0 | $4.3M | 61k | 69.98 | |
Tesaro | 0.9 | $3.8M | 130k | 29.48 | |
Universal Health Services (UHS) | 0.8 | $3.7M | 45k | 82.07 | |
Stericycle (SRCL) | 0.8 | $3.5M | 31k | 113.61 | |
Hca Holdings (HCA) | 0.8 | $3.5M | 67k | 52.51 | |
Medicines Company | 0.8 | $3.4M | 120k | 28.42 | |
Five Prime Therapeutics | 0.8 | $3.4M | 175k | 19.66 | |
Incyte Corporation (INCY) | 0.8 | $3.4M | 64k | 53.53 | |
Covance | 0.8 | $3.4M | 33k | 103.91 | |
WellCare Health Plans | 0.8 | $3.3M | 52k | 63.51 | |
Pharmacyclics | 0.7 | $3.2M | 32k | 100.22 | |
athenahealth | 0.7 | $3.1M | 20k | 160.26 | |
Charles River Laboratories (CRL) | 0.7 | $3.0M | 50k | 60.34 | |
Dicerna Pharmaceuticals | 0.7 | $3.0M | 105k | 28.25 | |
CHINA CORD Blood Corp | 0.7 | $2.9M | 718k | 4.00 | |
RTI Biologics | 0.7 | $2.8M | 686k | 4.08 | |
FEI Company | 0.7 | $2.8M | 28k | 103.02 | |
Jazz Pharmaceuticals (JAZZ) | 0.6 | $2.7M | 20k | 138.68 | |
Mylan | 0.6 | $2.6M | 53k | 48.83 | |
Theravance | 0.6 | $2.6M | 83k | 30.94 | |
Ultragenyx Pharmaceutical (RARE) | 0.6 | $2.5M | 52k | 48.89 | |
Prothena (PRTA) | 0.6 | $2.5M | 65k | 38.31 | |
Cerner Corporation | 0.6 | $2.4M | 42k | 56.26 | |
Regeneron Pharmaceuticals (REGN) | 0.5 | $2.3M | 7.5k | 300.27 | |
Cubist Pharmaceuticals | 0.5 | $2.2M | 30k | 73.17 | |
Castlight Health | 0.5 | $2.1M | 100k | 21.22 | |
Receptos | 0.5 | $2.1M | 50k | 41.94 | |
Advisory Board Company | 0.5 | $2.0M | 31k | 64.26 | |
Mednax (MD) | 0.5 | $2.0M | 33k | 61.97 | |
WuXi PharmaTech | 0.5 | $1.9M | 53k | 36.86 | |
Kindred Biosciences | 0.4 | $1.7M | 93k | 18.53 | |
Alkermes (ALKS) | 0.4 | $1.6M | 36k | 44.08 | |
Novavax | 0.3 | $1.5M | 325k | 4.53 | |
Arrowhead Research | 0.3 | $1.2M | 75k | 16.43 | |
Infinity Pharmaceuticals (INFIQ) | 0.3 | $1.2M | 98k | 11.89 | |
EnteroMedics | 0.3 | $1.2M | 650k | 1.82 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $1.1M | 16k | 70.75 | |
AVANIR Pharmaceuticals | 0.2 | $1.1M | 300k | 3.67 | |
Gw Pharmaceuticals Plc ads | 0.2 | $1.1M | 18k | 59.38 | |
Exelixis (EXEL) | 0.2 | $882k | 249k | 3.54 | |
Concert Pharmaceuticals I equity | 0.2 | $801k | 60k | 13.45 | |
Puma Biotechnology (PBYI) | 0.1 | $388k | 3.7k | 104.08 |